Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0369 | ||||
| Gene Name | SLC45A2 | ||||
| Protein Name | Membrane-associated transporter protein | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | 1A1; AIM1; MATP; Melanoma antigen AIM1; OCA4; Protein AIM-1; SHEP5; SLC45A2; Solute carrier family 45 member 2 | ||||
| DT Family | Glycoside-Pentoside-Hexuronide (GPH):Cation Symporter Family ; | ||||
| Tissue Specificity | Expressed in most melanoma cell lines andmelanocytes. | ||||
| Function | This tranporter may meditates the transport of substances required for melanin biosynthesis. | ||||
| Endogenous Substrate(s) | Sucrose | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Sucrose
|
Phase 4 | Drug Info | Retinopathy of prematurity | 9B71.3 | [1] |
| References | |||||
| 1 | Identification of amino acids important for substrate specificity in sucrose transporters using gene shuffling. J Biol Chem. 2012 Aug 31;287(36):30296-304. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.